The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

The company will compete with a device Boston Scientific acquired for $850 million.

Boston Scientific ... rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment ...

Baker currently serves as chief medical officer of Neuromodulation at Boston Scientific, showcasing 35 years of pain management leadership. Arsenal’s CEO sees Baker’s arrival as timely, given their ...

Boston Scientific Corporation (NYSE ... and we're pleased to have completed our first [indiscernible] fluid management case in Chile. The service system is part of our interconnected StoneSmart ...

Boston Scientific has proven ... in spinal cord stimulation for chronic pain. The 2020 dip in profitability due to covid notwithstanding, management's efforts to streamline operations and enhance ...

Get to Know Boston Scientific ... management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and ...

If you’re on the fence about investing in Intuitive Surgical, Inc. or Boston Scientific Corporation because you’re ... and devices to treat neurological movement disorders and manage chronic pain, ...